Other languages Guided Therapeutics, Inc.

Equities

GTHP

US40171F5017

Market Closed - OTC Markets Other stock markets 12:23:29 2024-06-28 EDT			5-day change	1st Jan Change
0.12 ^USD	0.00%		+18.81%	-21.82%

05-14	Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-28	Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval	11-20
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13
Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30
Guided Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	23-03-29
Guided Therapeutics, Inc. Announces CEO Changes	23-03-09
Guided Therapeutics, Inc. Announces Executive Changes	23-03-09
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval	22-12-21
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Guided Therapeutics Provides Update of Significant Progress in Chinese Clinical Study for Marketing Approval of the LuViva Advanced Cervical Scan	22-11-09
Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15
Guided Therapeutics, Inc. Receives Institutional Review Board Approval to Start Clinical Study for FDA Approval of the LuViva® Advanced Cervical Scan	22-07-20
Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16
Guided Therapeutics, Inc. Announces Testing Completion of First 150 Patients in Chinese Clinical Study and Receives Milestone Payment of $177,740	22-03-31
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30
Guided Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	22-03-29
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Guided Therapeutics, Inc.

Equities

GTHP

US40171F5017

Other languages

Filters